Tvardi Therapeutics (TVRD) Debt by Year
Tvardi Therapeutics, Inc. held $20.7M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Tvardi Therapeutics, Inc. has filed alongside them.
Ticker history: CARA became TVRD (Tvardi Therapeutics, Inc.) on . Earlier news and filings retain their original names and dates. View CARA history.
Annual figures, oldest first. Point at a bar to read its period.
TVRD Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | N/A | $30.3M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $20.7M-34.4% | $31.6M-38.9% | $51.8M-18.8% | $63.7M+373.8% | $13.5M-57.5% | $31.7M+73.1% | $18.3M+21.4% | $15.1M+60.6% | $9.4M-22.4% | $12.1M-19.9% | $15.1M-71.3% | $52.7M+326.2% | $12.4M+1006.3% | $1.1M |
TVRD Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | $30.3M | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $15.8M-23.6% | $19.9M-42.0% | $20.7M-34.4% | $21.4M-42.2% | $20.6M-58.1% | $34.2M-27.2% | $31.6M-38.9% | $37.1M-41.1% | $49.2M-15.5% | $47.0M-0.8% | $51.8M-18.8% | $62.9M+46.9% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Tvardi Therapeutics, Inc. financials
Frequently Asked Questions
Tvardi Therapeutics, Inc. held $20.7M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period.
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Tvardi Therapeutics, Inc. (TVRD) reported on that line in every period on record.